IRESSEF to evaluate a new molecular diagnostic test for hepatitis C: the Genedrive® HCV kit

Standard hepatitis C (HCV) diagnostic tests are complex and therefore their availability is often limited to specialized laboratories. With the introduction of direct-acting antivirals, the diagnostic algorithm is simplified and treatment can now be initiated immediately after a positive molecular test. Decentralized molecular diagnostics will make HCV screening widely available and will quickly identify patients…